Association between TSH levels and hepatic steatosis is mediated by metabolic syndrome factors (2017)
- Authors:
- Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
- Unidade: HU
- Subjects: FATORES DE RISCO; HORMÔNIOS TIREOIDIANOS; OBESIDADE
- Keywords: SÍNDROME METABÓLICA
- Language: Inglês
- Imprenta:
- Publisher: American Heart Association
- Publisher place: Dallas
- Date published: 2017
- Source:
- Título: Circulation
- ISSN: 0009-7322
- Volume/Número/Paginação/Ano: v. 136, suppl. 1, nov. 2014
- Conference titles: Resuscitation Science Symposium: Scientific Sessions 2017
-
ABNT
JANOVSKY, Carolina C et al. Association between TSH levels and hepatic steatosis is mediated by metabolic syndrome factors. Circulation. Dallas: American Heart Association. . Acesso em: 11 mar. 2026. , 2017 -
APA
Janovsky, C. C., Cesena, F. H., Tabone, V. A., Conceição, R. D., Santos, R. D., & Bittencourt, M. S. (2017). Association between TSH levels and hepatic steatosis is mediated by metabolic syndrome factors. Circulation. Dallas: American Heart Association. -
NLM
Janovsky CC, Cesena FH, Tabone VA, Conceição RD, Santos RD, Bittencourt MS. Association between TSH levels and hepatic steatosis is mediated by metabolic syndrome factors. Circulation. 2017 ; no 2014[citado 2026 mar. 11 ] -
Vancouver
Janovsky CC, Cesena FH, Tabone VA, Conceição RD, Santos RD, Bittencourt MS. Association between TSH levels and hepatic steatosis is mediated by metabolic syndrome factors. Circulation. 2017 ; no 2014[citado 2026 mar. 11 ] - Heart disease and stroke statistics-2019 update: a report From the American Heart Association
- The yield of downstream tests after exercise treadmill testing: a prospective cohort study
- Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit
- Coronary calcium score vs. computed tomography angiography as tools to stratify cardiovascular risk
- Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study
- Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit
- Impact of coronary remodeling on fractional flow reserve [letter]
- Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients
- Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis)
- Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
